 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Provalis plc
 |
Provalis plc |
 |
 |
 |
PROFILE |
 |
Provalis focuses on diagnostic equipment and prescription drugs. Its Provalis Medical Diagnostics unit makes glucose monitors for diabetics, bone densitometers for osteoporosis, and other diagnostic equipment. Provalis Healthcare sells branded drug treatments for gastrointestinal and dermatological conditions, migraines, osteoporosis, and other ailments. Provalis continues some drug R&D work, focusing mainly on vaccines, using profits from its health care and diagnostic divisions to fund its work. The company has a contract with the US government to supply its Glycosal blood sugar monitors for a large diabetes study in that country.
COMPETITION |
 |
AstraZeneca PLC (AZN)
Johnson & Johnson (JNJ)
Roche Group (ROHHY)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: June
2000 Sales (mil.): 10.30
1-Yr. Sales Growth: (29.0)%
Employees: 124
Revenue per employee: $83,064.52
KEY PEOPLE |
 |
Phil Gould
CEO
Mark Keen
CFO
CONTACT INFO |
 |
Newtech Sq., Deeside Industrial Park
Deeside Flintshire CH5 2NT, United Kingdom
Phone: 44-1244-288-888
Fax: 44-1244-280-221
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |